title: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: B
authors.initials: B
authors.lastname: Escudier
authors.affiliation: IRCCS San Matteo University Hospital Foundation, Pavia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Porta
authors.affiliation: Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
authors.forename: M
authors.initials: M
authors.lastname: Schmidinger
authors.affiliation: Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Algaba
authors.affiliation: CHU Bicêtre, Université Paris XI, Kremlin Bicêtre, France.
authors.forename: J J
authors.initials: JJ
authors.lastname: Patard
authors.affiliation: Institute of Cancer Research and Royal Marsden Hospital, London, UK Monash University, Melbourne, Australia.
authors.forename: V
authors.initials: V
authors.lastname: Khoo
authors.affiliation: Cambridge Biomedical Campus, Cambridge, UK.
authors.forename: T
authors.initials: T
authors.lastname: Eisen
authors.affiliation: Institute of Cancer Research and Royal Marsden Hospital, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Horwich
mesh_terms: D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006287:Health Planning Guidelines; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D012955:Societies, Medical / Q000592:standards*